o january 12 january 26 - usf health

BIOTECHNOLOGY FORUM SPRING 2017

Thursday AT 12:30PMROOM MDC 1055

FOR MOREINFORMATION

PLEASE [email protected]

PRO

FESS

IONAL S

CIENCE MASTER’S IN BIOTECHNO

LOG

Y DEPARTMENT OF MOLECULAR M

EDICIN

E

Jenny PetersonDirectorXogene

March 9

February 9Marina Bastawrous, PSMResearch ScientistMorphogenesis, Inc.

March 23Jennifer LutherFormulation Research Assoc. CoreRx Pharm.

January 26Jim Leahy, Ph.D. Chemistry ProfessorUniversity of South Florida

Thomas Malcolm, Ph.D.CEO and PresidentExcision Biotherapeutics

Julie Pearson, Ph.D.Chief Forensic ToxicologistHillsborough Co. Medical Examiner

February 23

Greg Shear, PSMResearch ScientistBristol-Myers Squibb

April 6

January 12David Mitchell, PhD Director, PSM Biotech University of South Florida

April 20

mailto:[email protected]



TUESDAYS AT 12:30PMROOM MDC 1507

FOR MOREINFORMATION


PRO

FESS

IONAL S


LOG


EDICIN

E

Kevin Sill, Ph.DChief Science OfficerIntezyne Technologies

March 22

February 23Rajesh Nair, Ph.DVP of OperationsTransGenex Nanobiotech

April 5TBA

February 9Ashraf Dehlawi, P.M.SChief Clinical Officer Morphogenesis

Julie Pearson, PhD.Chief Forensic ToxicologistHillsborough Co. Medical Examiner

March 8

Paul Skultety, Ph.D.VP Pharm. Development Xcelience

April 19

January 26John Cronan, PhDPresident & CEOMagellan Bioscience




THURSDAYS AT NOONROOM MDC 1507

FOR MOREINFORMATION


PRO

FESS

IONAL S


LOG


EDICIN

E

Peter Condon, PhDVP, Product DevelopmentRapid Pathogen Screening

Spring Break

Kevin Sill, PhDChief Scientific OfficerIntezyne Technologies

April 16

February 19

February 5

January 22

April 2

John Cronan, PhDPresident & CEOMagellan Bioscience

April 30

March 5

March 19

Meghan Gentilini,MSProject Leader Morphogenesis

Tammy Spain, PhDSenior Member Draper Laboratory

Sam Mohapatra, PhDCo-Founder TransGenex Nanobiotech

Marc Giulianotti, MBADirector, Chemistry OperationsTorrey Pines Institutefor Molecular Studies



z

Michael Lawman, PhDPresident and ChairmanMorphogenesis, Inc.

John Cronan, PhDPresident and CEOMagellan Bioscience

Tammy Spain, PhDSenior MemberDraper Corporation

Marc Giullianotti, Ph.D.Director of Chemistry OperationsTorrey Pines

Michael LanceResearch and DevelopmentNephron Pharmaceuticals

Andreas BoecklFounderFlurry Powders

April 3

March 6

February 20

February 6

January 23

January 9


THURSDAYS AT NOONROOM MDC 1507

FOR MOREINFORMATION


Paul Skultety, PhDDirector, Pharmaceutical Development ServicesXcelience, LLC

March 20

Kevin Sill, PhDChief Science officerIntezyne Technologies

April 17



z

John Cronan, PhDPresident and Chief Executive Officer, Research and DevelopmentMagellan Bioscience

Jeremiah Tipton, PhDDirector,Proteomics and Mass Spectrometry

Drug Discovery and Development-USF (CDDI)

Michael Lawman, PhDChairman, Research and DevelopmentMorphogenesis, Inc.

Carlos Santos, PhDSenior Vice president, Product Development, Regulatory Affairs

Accentia Biopharmaceuticals

Michael LanceResearch and DevelopmentNephron Pharmaceuticals

John SantinoChief Executive Officer, Research and Development

Biostem US

November 29

November 1

October 18

October 4

September 20

September 6

BIOTECHNOLOGY FORUM FALL 2012

THURSDAYS AT NOONROOM MDA 1096

FOR MOREINFORMATION




BIOTECHNOLOGY FORUM, FALL 2011 Thursdays 12 Noon, Room MDC 1507

Julie G. Allickson, PhD, MS, MT(ASCP) Vice President Laboratory Operations, R&D Current Characterization And Studies

Of A Novel Menstrual Stem Cell

Edward Turos, PhD; Co-Founder & Kerriann Greenhalgh, PhD; Co-Founder, CEO A Molecular Diagnostic Assay For The Selection Of Topical Products For

Wound Healing Javier Torres-Roca, MD Co-Founder & Chief Scientific Officer A Molecular Diagnostic Assay For The Diagnosis of Tumor Radiosensitivity Joachim Sasse, PhD; President Immunoassay and High Throughput Screening at BioMedTech, Inc

BioFlorida 14th Annual Conference, and Career Workshops; Marriott Tampa Waterside

Todd Daviau, PhD; CEO Innovative Development Solutions at CoreRx Pharmaceuticals

Bill Baker, PhD; Director USF Center for Drug Discovery and Innovation

Innovative Pharmaceuticals: From Research Bench To Point-Of-Care Fiona Crawford, PhD; CTO & Ass. CSO Targeted Drug Discovery For Alzheimer’s Disease

BioMedTech, Inc “The Immunoassay And High Throughput Screening Company”

September 22

October 6

October 20

September 8

October 23 - 25

November 3

November 17

December 1

CENTER FOR DRUG DISCOVERY AND INNOVATION CDDI

Archer Pharmaceuticals

For more information, please contact: [email protected]

For more information, please contact: Inge Wefes, PhD, Director, PSM Master’s Programs, Dept. Molecular Medicine (813) 974-5360, [email protected]

GMS 7930 - BIOTECHNOLOGY FORUM Seminars on Research and Development in Tampa Bay Companies

Department of Molecular Medicine USF College of Medicine

Fall 2010

Every second Thursdays, 11:00 AM -12noon, room MDC 1507 September 9 Dr. Joseph Cuiffi Principal Investigator DRAPER LABORATORY September 23 Dr. Joseph Zendegui

President and CEO PROTEACEL

October 7 Dr. Jennifer Smith Principle Scientist CLARO SCIENTIFIC October 14 USF Graduate Student

RESEARCH SYMPOSIUM Interdisciplinary Research Building IDRB, Spectrum Blvd.

October 21 Dr. Shyam Mohapatra Founder and Chairman TRANSGENEX NANOBIOTECH November 4 Dr. Deepak Agraval

Director for Bioinformatics, Research and Development

M2GEN November 18 Dr. Mihaela Popa, Dr. Amy McCord

Senior Managers of Clinical Research RETINAPHARMA TECHNOLOGIES December 2 Dr. Guy Bradley Principal Investigator TAMPA BAY RESEARCH INSTITUTE

For more information, please contact: Inge Wefes, Ph.D, Director, USF Biotechnology Master’s Program, (813) 974-5360, [email protected]

BIOTECHNOLOGY FORUM Seminars on Research and Development in Tampa Bay Companies

Department of Molecular Medicine USF College of Medicine

Fall 2009

Thursdays 12 noon, room MDC 1507 September 3 Jonathan Rios-Doria, Ph.D Head Of Preclinical Development INTEZYNE TECHNOLOGIES September 17 Derek G. Hennecke, MBA, President, CEO

XCELIENCE FORMULATION DEVELOPMENT

October 1 Carlos Santos, Ph.D, CSO ACCENTIA BIOPHARMACEUTICALS/ BIOVEST INTERNATIONAL

October 8 USF Graduate Student Research Symposium Spectrum Blvd. October 15 Sue Ann Berend, Ph.D

Laboratory Director GENZYME GENETICS October 29 Todd Daviau, Ph.D

Chief Executive Officer MAGELLAN BIOSCIENCE

November 12 Seyoung Jang, Ph.D, CEO

Edward Turos, Ph.D, CSO NANOPHARMA TECHNOLOGIES

November 19 Pat Lawman, Ph.D

Chief Executive Officer MORPHOGENESIS

December 3 Jean-Francois Rossignol, MD, PhD, F.R.S.C. Chief Scientific Officer ROMARK LABORATORIES

o january 12 january 26 - usf health

Documents